Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.

TitleAndrogen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.
Publication TypeJournal Article
Year of Publication2001
AuthorsWaltregny D, Leav I, Signoretti S, Soung P, Lin D, Merk F, Adams JY, Bhattacharya N, Cirenei N, Loda M
JournalMol Endocrinol
Volume15
Issue5
Pagination765-82
Date Published2001 May
ISSN0888-8809
KeywordsAndrogen Antagonists, Animals, Blotting, Western, Cell Cycle Proteins, Cell Differentiation, Cell Division, Cyclin-Dependent Kinase Inhibitor p27, Cyclin-Dependent Kinases, Epithelial Cells, Fluorescent Antibody Technique, Flutamide, G1 Phase, Gene Expression Regulation, In Situ Hybridization, Kinetics, Male, Microtubule-Associated Proteins, Orchiectomy, Precipitin Tests, Prostate, Rats, Testosterone, Tumor Suppressor Proteins, Up-Regulation
Abstract

Androgens control both growth and differentiation of the normal prostate gland. However, the mechanisms by which androgens act upon the cell cycle machinery to regulate these two fundamental processes are largely unknown. The cyclin-dependent kinase (cdk) inhibitor p27 is a negative cell cycle regulator involved in differentiation-associated growth arrest. Here, we investigate the role and regulation of p27 in the testosterone proprionate (TP)-stimulated regeneration of the ventral prostate (VP) of castrated rats. Continuous TP administration to castrated rats triggered epithelial cell proliferation, which peaked at 72 h, and then declined despite further treatment. Castration-induced atrophy of the VP was associated with a significant increase in p27 expression as compared with the VP of intact animals. Twelve hours after the initiation of androgen treatment, total p27 levels as well as its fraction bound to cdk2, its main target, significantly dropped in the VP of castrated rats. Thereafter, concomitantly to the induction of epithelial cell proliferation, the glandular morphology of VP was progressively restored at 48-96 h of TP treatment. During this period of the regenerative process, whereas both proliferating basal and secretory epithelial cells did not express p27, the protein was selectively up-regulated in the nonproliferating secretory epithelial compartment. This up-regulation of p27 expression was coincident with an increase in its association with, and presumably inhibition of, cdk2. At each time point of TP treatment, p27 abundance in the VP was inversely correlated with the level of its proteasome-dependent degradation activity measured in vitro in VP lysates, whereas only slight changes in the amount of p27 transcripts were detected. In addition, the antiandrogen flutamide blocked maximal TP-induced p27 degradation completely. Finally, the expression of skp2, the ubiquitin ligase that targets p27 for degradation, was seen to increase with androgen administration, preceding maximal proliferation and concomitantly to augmented p27 degradation activity. Taken together, our data indicate that androgens mediate both proliferation and differentiation signals in normal prostate epithelial cells in vivo, through regulation of p27.

DOI10.1210/mend.15.5.0640
Alternate JournalMol Endocrinol
PubMed ID11328857
Grant List5RO1CA-81755-03 / CA / NCI NIH HHS / United States
Related Faculty: 
Massimo Loda, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700